Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
152.63
-0.39 (-0.25%)
Dec 27, 2024, 4:00 PM EST - Market closed
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Quest Diagnostics stock have an average target of 168.14, with a low estimate of 135 and a high estimate of 185. The average target predicts an increase of 10.16% from the current stock price of 152.63.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for DGX stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 2 | 2 | 3 |
| Hold | 9 | 9 | 9 | 8 | 8 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $145 → $172 | Hold → Buy | Upgrades | $145 → $172 | +12.69% | Dec 17, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $179 → $182 | Strong Buy | Maintains | $179 → $182 | +19.24% | Dec 13, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $185 | Strong Buy | Initiates | $185 | +21.21% | Dec 10, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $150 → $165 | Hold | Maintains | $150 → $165 | +8.10% | Oct 28, 2024 |
| Mizuho | Mizuho | Buy Maintains $160 → $174 | Buy | Maintains | $160 → $174 | +14.00% | Oct 24, 2024 |
Financial Forecast
Revenue This Year
9.93B
from 9.25B
Increased by 7.33%
Revenue Next Year
10.78B
from 9.93B
Increased by 8.60%
EPS This Year
8.99
from 7.49
Increased by 20.04%
EPS Next Year
9.85
from 8.99
Increased by 9.57%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.4B | 11.5B | 12.0B | ||
| Avg | 9.9B | 10.8B | 11.2B | ||
| Low | 9.6B | 9.9B | 10.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.4% | 15.4% | 10.9% | ||
| Avg | 7.3% | 8.6% | 3.7% | ||
| Low | 3.8% | -0.1% | -6.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.39 | 10.72 | 11.98 | |||
| Avg | 8.99 | 9.85 | 10.72 | |||
| Low | 8.68 | 9.46 | 10.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 25.3% | 19.2% | 21.6% | |||
| Avg | 20.0% | 9.6% | 8.8% | |||
| Low | 15.9% | 5.2% | 2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.